0001209191-23-002030.txt : 20230105
0001209191-23-002030.hdr.sgml : 20230105
20230105180032
ACCESSION NUMBER: 0001209191-23-002030
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230103
FILED AS OF DATE: 20230105
DATE AS OF CHANGE: 20230105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kaufmann Gunnar F.
CENTRAL INDEX KEY: 0001786754
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50549
FILM NUMBER: 23512763
MAIL ADDRESS:
STREET 1: C/O ONCTERNAL THERAPEUTICS, INC.
STREET 2: 12230 EL CAMINO REAL, SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oncternal Therapeutics, Inc.
CENTRAL INDEX KEY: 0001260990
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 621715807
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 230
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 434-1113
MAIL ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 230
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: GTX INC /DE/
DATE OF NAME CHANGE: 20030822
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-01-03
0
0001260990
Oncternal Therapeutics, Inc.
ONCT
0001786754
Kaufmann Gunnar F.
12230 EL CAMINO REAL, SUITE 230
SAN DIEGO
CA
92130
0
1
0
0
Chief Scientific Officer
Common Stock
2023-01-03
4
F
0
6266
1.02
D
66726
D
Shares withheld by the Issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units.
/s/Chase C. Leavitt, Attorney-in-fact
2023-01-05